Anandamide Signaling Can Involve TRPV1 as Well as Cannabinoid Receptors

An anandamide-related effect should not automatically be assigned to CB1. A review of alcohol–endocannabinoid research identifies TRPV1 as another relevant target requiring separate mechanistic testing.

The endogenous ligand has more than one possible target

Pava and Woodward discuss anandamide activation of TRPV1 alongside its relationship to the endocannabinoid system. They also summarize evidence that alcohol can potentiate TRPV1-mediated responses. An effect involving anandamide therefore does not identify its receptor solely from the ligand’s name.

Receptor specificity needs evidence

Experiments using selective interventions can help distinguish CB1, CB2 and non-cannabinoid-receptor contributions. A compound changing several pathways may be useful experimentally while leaving the specific mechanism unresolved.

A proposed pathway is not a clinical finding

The review presents non-CB1 signaling as a research direction in understanding alcohol-related behavior and physiology. It does not establish that TRPV1 explains all endocannabinoid effects or that manipulating it treats human alcohol dependence. This distinction also matters for cannabis claims: shared involvement of a biological target does not make an endogenous ligand, purified THC and a cannabis preparation equivalent interventions. The actual ligand, target and measured response must remain identifiable.

Related reading: Alcohol–Endocannabinoid Reviews Need to Keep Stages of Dependence Separate.

Research cited

Pava MJ, Woodward JJ. A Review of the Interactions between Alcohol and the Endocannabinoid System: Implications for Alcohol Dependence and Future Directions for Research (2012). The experiments discussed here are described through this supplied review.